While U.S. heart failure readmissions fall, deaths rise
September 20, 2017
DALLAS – CMS’s penalties for heart failure outcomes may have unintentionally pushed hospitals toward “gaming the system.”
Ivabradine cut mortality in HFrEF patients not on beta-blocker
September 7, 2017
BARCELONA – Secondary analysis of SHIFT trial suggests potential expanded role for heart failure agent.
Despite global decline, rheumatic heart disease persists in poorest regions
August 24, 2017
From 1990 to 2015, the percentage of deaths worldwide due to rheumatic heart disease rose in endemic regions of Oceania, South Asia, and central sub-Saharan Africa.
FDA approves first spironolactone oral suspension
August 9, 2017
After more than 50 years on the U.S. market, spironolactone is available in liquid form, bypassing the compounding pharmacist.
Study: No increased mortality with ACA-prompted readmission declines
July 18, 2017
Reductions in 30-day hospital readmission rates among Medicare fee-for-service beneficiaries are weakly but significantly correlated with reductions in hospital 30-day mortality rates after discharge.
Plasma biomarker distinguishes ARDS, acute heart failure
July 15, 2017
WASHINGTON – The biomarker identified acute respiratory distress syndrome patients who were sicker and more responsive to conservative fluid management.
Rest dyspnea dims as acute heart failure treatment target
June 19, 2017
PARIS – Results from two new acute heart failure trials “mark the start of a new era.”
HFrEF mortality halved when treatment matches guidelines
June 14, 2017
PARIS – Full adherence to heart failure guidelines works.
Angiotensin II may improve vasopressors’ efficacy
June 14, 2017
Adding a certain hormone could strengthen treatment options for vasodilatory shock patients.
Atrial fibrillation blunts beta-blockers for HFrEF
June 11, 2017
Do beta-blockers alter mortality in HFrEF with atrial fib??